Admin

``` The regulatory stance on Wall Street is undergoing a major shift. According to media reports on September 15, Paul Atkins, the new Chairman of the U.S. Securities and Exchange Commission (SEC) appointed by President Trump, is moving to abolish his predecessor's aggressive enforcement agenda, shifting towards a

``` Recently, Bank of America predicted that emerging markets will see larger capital inflows early next year, as a weaker dollar and further confirmation of emerging economies' resilience will prompt global investors to accelerate their shift from US assets to emerging markets. David Hauner, Head of Global Emerging Markets Fixed

``` The possibility of a merger between Tesla and Musk’s AI startup xAI is evolving from market speculation to a serious discussion. On Sunday, Anthony Scaramucci, founder of SkyBridge Capital, posted on social platform X, stating that as Musk accelerates the integration of AI into his business landscape, a merger

``` A divided Federal Reserve is preparing to implement its first rate cut of the year, but the decision-making process is fraught with contradictions: on one side is a weakening job market, and on the other, inflation risks brought by President Trump’s tariff policies. Most investors expect the Federal Open

``` J.P. Morgan warns that after Pop Mart's price soared more than 200% this year, “valuation has reached perfect expectations”, the current cost-effectiveness of entering the market has significantly decreased, and the risk-reward ratio is deteriorating rapidly. On Monday (September 15), Pop Mart plunged again, dropping as low

``` Recently, Zhanyan Biotechnology Co., Ltd. (“Zhanyan Biotechnology”) was listed on the New Third Board basic tier. Although Zhanyan Biotechnology has not yet started the IPO counseling process, the market generally expects the New Third Board listing may be aimed at the Beijing Stock Exchange. Zhanyan Biotechnology has been deeply involved